TNFSF13 and primary central nervous system lymphoma: To evaluate the role of APRIL and BAFF as therapeutic biomarkers in PCNSL, we examined their CSF levels in 46 patients with newly diagnosed (untreated) or relapsed PCNSL and in 21 patients with CR after MTX-based polychemotherapy.